四个自发报告数据库中药品不良反应报告完整性的评估
该研究基于vigiGrade完整性工具评估2014至2023年加拿大、美国FAERS、英国黄卡和丹麦四个自发报告数据库中ADR报告的信息完整性。
要点
- 给药途径是英国、丹麦和加拿大数据库中最常缺失的信息,完整率分别为44%、55%和58%。
- FAERS中最常缺失的信息是事件日期,完整率为50%。
- 报告者信息完整性最高,接近100%。
核心结论
- 不同变量的信息完整性存在差异,给药途径和事件日期是常被遗漏的信息。
- 提高报告者对提供完整信息的意识对于收集完整数据和信号检测至关重要。
研究设计与样本
- 研究使用加拿大警戒不良反应在线数据库、美国FDA不良事件报告系统(FAERS)、英国黄卡计划和丹麦药品管理局ADR数据库中2014至2023年可自由获取的ADR报告。
- 评估变量基于vigiGrade完整性工具选择,使用描述性统计报告完整性,卡方检验分析完整性按报告严重程度的差异。
主要发现
- 最常完整的信息是主要报告者,完整性接近100%。
- 最常遗漏的信息是给药途径,英国黄卡计划完整率为44%,丹麦数据库为55%,加拿大数据库为58%。
- 在FAERS中,事件日期是最常遗漏的信息,完整率为50%。
临床怎么用
- 临床药学智能体医生在解读ADR报告时应关注给药途径和事件日期等关键信息的缺失情况,以评估报告质量。
- 在ADR上报过程中应强调提供完整信息,以支持信号检测和药物警戒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the completeness of information provided in adverse drug reaction (ADR) reports in 4 spontaneous report databases. METHODS: The study was conducted using freely accessible ADR reports from the Canada Vigilance Adverse Reaction Online Database, the US Food and Drug Administration Adverse Event Reporting System (FAERS) database, the UK Yellow Card Scheme and the Danish Medicines Agency ADR Database, covering the period 2014-2023. The variables used to evaluate the completeness of ADR reports were selected based on the vigiGrade completeness tool. Descriptive statistics were used to report the completeness of information in each ADR report, while chi-square tests were used to analyse differences in completeness by seriousness of report. RESULTS: In total, 290 079 individual case safety reports were analysed: 4289 from the Canadian database; 269 763 from the FAERS database; 13 624 from the UK Yellow Card Scheme; and 2403 from the Danish database. The most frequently completed information was the primary reporter, with nearly 100% completeness. The most frequently omitted information was the route of administration, with completion scores of 44% in the UK Yellow Card Scheme, 55% in the Danish database and 58% in the Canadian database. In FAERS, the event date was the most frequently omitted information with a completeness rate of 50%. CONCLUSION: The completeness of information varied across different variables, with information frequently omitted for route of administration and event date. Enhancing awareness about providing complete information during ADR reporting is essential for collecting complete data and allowing signal detection.
引用
- Dedefo MG, Kassie GM, Gebreyohannes EA, et al. Completeness of spontaneously reported adverse drug reactions in 4 databases. Br J Clin Pharmacol. 2025. PMID: 40717560. doi:10.1002/bcp.70182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。